| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| Targets |
Arabinosyltransferases EmbA, EmbB, and EmbC (mycobacterial cell wall synthesis).
|
|---|---|
| ln Vitro |
Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
Ethambutol inhibits arabinosyltransferases involved in the biosynthesis of arabinogalactan and lipoarabinomannan, with MIC values typically in the range of 1–5 µg/mL against susceptible Mycobacterium tuberculosis strains. It also inhibits RNA synthesis and decreases tubercle bacilli replication. The deuterated form has equivalent antimycobacterial activity to the unlabeled parent. |
| ln Vivo |
In vivo, ethambutol is effective in murine models of tuberculosis when administered orally at doses of 25–100 mg/kg/day, reducing bacterial burden in lungs and spleen. It is used in combination with isoniazid, rifampicin, and pyrazinamide. The deuterated form is used for pharmacokinetic profiling.
|
| Enzyme Assay |
Arabinosyltransferase activity is measured using membrane fractions from mycobacteria and radiolabeled sugar donors, with incorporation into lipid-linked acceptors quantified. MICs are determined by broth microdilution in Middlebrook 7H9 medium according to CLSI guidelines.
|
| Cell Assay |
In vitro cell experiments use Mycobacterium tuberculosis cultures or macrophage infection models. THP-1 or primary macrophages are infected with M. tuberculosis and treated with ethambutol (0.1–10 µg/mL), and intracellular bacterial survival is assessed by CFU counting. Cytotoxicity is evaluated in HepG2 cells.
|
| Animal Protocol |
Mouse models of tuberculosis (BALB/c or C57BL/6) are infected by aerosol or intravenous routes and treated with ethambutol by oral gavage at 25–100 mg/kg/day for 4–8 weeks. Bacterial burden in lungs and spleen is quantified by CFU. Plasma concentrations are measured by LC-MS/MS using the d8-labeled internal standard.
|
| References |
| Molecular Formula |
C10H24N2O2
|
|---|---|
| Molecular Weight |
204.309762954712
|
| Exact Mass |
212.233
|
| CAS # |
1129526-23-3
|
| Related CAS # |
Ethambutol;74-55-5
|
| PubChem CID |
25217874
|
| Appearance |
Typically exists as solid at room temperature
|
| LogP |
-0.1
|
| tPSA |
64.5
|
| Hydrogen Bond Donor Count |
4
|
| Hydrogen Bond Acceptor Count |
4
|
| Rotatable Bond Count |
9
|
| Heavy Atom Count |
14
|
| Complexity |
109
|
| Defined Atom Stereocenter Count |
2
|
| SMILES |
[2H]C([2H])([C@H](CC)NC([2H])([2H])C([2H])([2H])N[C@@H](CC)C([2H])([2H])O)O
|
| InChi Key |
AEUTYOVWOVBAKS-MKWMBDJFSA-N
|
| InChi Code |
InChI=1S/C10H24N2O2/c1-3-9(7-13)11-5-6-12-10(4-2)8-14/h9-14H,3-8H2,1-2H3/t9-,10-/m0/s1/i5D2,6D2,7D2,8D2
|
| Chemical Name |
(2S)-1,1-dideuterio-2-[[1,1,2,2-tetradeuterio-2-[[(2S)-1,1-dideuterio-1-hydroxybutan-2-yl]amino]ethyl]amino]butan-1-ol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.8945 mL | 24.4726 mL | 48.9452 mL | |
| 5 mM | 0.9789 mL | 4.8945 mL | 9.7890 mL | |
| 10 mM | 0.4895 mL | 2.4473 mL | 4.8945 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.